• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

9780323986557
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
544.26 zł
462.62 zł Save 81.64 zł Tax included
Lowest price within 30 days before promotion: 462.62 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma:: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Product Details
Elsevier
94144
9780323986557
9780323986557

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
450
  • Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes
    The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes
    What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
    Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals
    Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors
    Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma
    Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma
    Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon
    Cytotoxic Chemotherapy in Advanced Pancreatic Cancer
    PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma
    Genetics of Pancreatic Neuroendocrine Tumors
    Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma
Comments (0)